Ondansetron Safety and Efficacy in Asthma Patients

Introduction to Ondansetron Use

• Ondansetron can be safely used in patients with asthma who are experiencing vomiting, as there are no contraindications or safety concerns specific to asthma for this medication 1, 2

Key Safety Considerations

• The concern about antiemetics and respiratory disease specifically applies to zanamivir (an inhaled influenza antiviral), not ondansetron, which is contraindicated in patients with underlying airway disease due to risk of bronchospasm 3

Recommended Dosing

• For adults with acute vomiting, administer ondansetron 4-8 mg orally or IV every 8-12 hours, with a maximum daily dose of 24 mg 1, 2

Clinical Approach

• Administer ondansetron without hesitation in asthma patients with vomiting, while simultaneously addressing the underlying asthma exacerbation 1
• Ensure adequate hydration alongside antiemetic therapy 1
• If ondansetron alone is insufficient, consider adding prochlorperazine 5-10 mg every 6 hours or metoclopramide 10 mg every 6-8 hours 1

Potential Adverse Effects

• QT interval prolongation is a rare but potential concern in patients with cardiac conditions 2